{
  "hash": "537b19cec22ea5c52ec41475194c175f",
  "result": {
    "engine": "knitr",
    "markdown": "---\noutput: html_document\neditor_options: \n   chunk_output_type: console\n---\n\n\n\n# Drug Rebate Program {#sec-rebate}\n\n> __Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Program__\n\nThe Table below, updated weekly, contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last quarterly update of the __Drug Products in the Medicaid Drug Rebate Program (MDRP)__ database. Each file on this table represents a snapshot of data in the system and is not updated by subsequent changes. Once the covered outpatient drugs in each of these files appear in the quarterly MDRP database, the file will be removed from this table. States can utilize these files to identify newly reported covered outpatient drugs.\n\n## Metadata\n\n\n::: {.cell layout-align=\"center\"}\n<pre class=\"r-output\"><code>  [ROWS] 932 \n[FIELDS] 17 \n</code></pre>\n:::\n\n\n## Dictionary\n\n::: panel-tabset\n\n### Newly Reported Drugs\n\n\n::: {.cell layout-align=\"center\"}\n<pre class=\"r-output\"><code><span style='color: #555555;'> 1</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>ndc1</span>: <span style='color: #555555;'>Labeler Code - First segment of National Drug Code (NDC1) that identifies the manufacturer, labeler, relabeler, packager, repackager or distributor of the drug.</span>\n\n<span style='color: #555555;'> 2</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>ndc2</span>: <span style='color: #555555;'>Product Code - Second segment of National Drug Code (NDC2)</span>\n\n<span style='color: #555555;'> 3</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>ndc3</span>: <span style='color: #555555;'>Package Size - Third segment of National Drug Code (NDC3)</span>\n\n<span style='color: #555555;'> 4</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>labeler_name</span>: <span style='color: #555555;'>Labeler Name: Name of labeler as it appears on the signed rebate agreement.</span>\n\n<span style='color: #555555;'> 5</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>labeler_status</span>: <span style='color: #555555;'>Labeler Status: Active or Terminated</span>\n\n<span style='color: #555555;'> 6</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>fda_name</span>: <span style='color: #555555;'>The FDA Name should reflect the drug's name as reported to FDA; therefore, the FDA Name reported to CMS should correspond to the drug name on file with the FDA.</span>\n\n<span style='color: #555555;'> 7</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>cod_status</span>: <span style='color: #555555;'>Covered Outpatient Drug (COD) Status: A category that identifies whether or not a product meets the statutory definition of a covered outpatient drug in accordance with sections 1927(k)(2) to 1927(k)(4) of the Social Security Act. Numeric values; 8-digit field; format: MMDDYYYY. Valid Values: 01 = Abbreviated New Drug Application (ANDA) 02 = Biological License Application (BLA) 03 = New Drug Application (NDA) 04 = NDA Authorized Generic 05 = DESI 5* - LTE/IRS drug for all indications 06 = DESI 6* - LTE/IRS drug withdrawn from market 07 = Prescription Pre-Natal Vitamin or Fluoride 08 = Prescription Dietary Supplement/Vitamin/Mineral (Other than Prescription Pre-Natal Vitamin or Fluoride) 09 = OTC Monograph Tentative 10 = OTC Monograph Final 11 = Unapproved Drug - Drug Shortage 12 = Unapproved Drug - Per 1927(k)(2)(A)(ii) 13 = Unapproved Drug - Per 1927(k)(2)(A)(iii) Spaces = The Labeler has not reported this field to the Medicaid Drug Rebate Program. * NDCs with a COD Status of DESI 5/6 are not eligible for coverage or rebates under the Medicaid Drug Rebate Program.</span>\n\n<span style='color: #555555;'> 8</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>fda_application_number</span>: <span style='color: #555555;'>FDA Application Number/OTC Monograph Number: For drugs with a COD status of ANDA, BLA, NDA, or NDA Authorized Generic, this is the application number (assigned by the FDA for approval to market a drug or biological in the United States) under which the NDC is currently marketed. Numeric values; 7-digit field; padded with leading zeros as needed. For drugs with a COD status of OTC Monograph Tentative or Final, this is the FDA's regulatory citation for the OTC. Alpha-numeric values; 7-digit field. For drugs with a COD Status of OTC Monograph Final, the first four characters are a constant of PART; the last three characters are the numeric values for the appropriate regulatory citation for the product (e.g., 225). For drugs with a COD Status of OTC Monograph Tentative, the first four characters are a constant of PART; the last three characters are the numeric values for the appropriate regulatory citation for the product, or three zeros if a Monograph Number is not available. For drugs with a COD Status other than ANDA, BLA, NDA, NDA Authorized Generic, OTC Monograph Final, or OTC Monograph Tentative, the FDA Application Number/OTC Monograph Number field should be zero-filled.</span>\n\n<span style='color: #555555;'> 9</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>drug_category</span>: <span style='color: #555555;'>Drug Category: This field indicates whether the drug is single source (S), innovator multiple source (I), or non-innovator multiple source (N). 1-character field. Valid Values: N = Non-innovator multiple source S = Single source I = Innovator multiple source</span>\n\n<span style='color: #555555;'>10</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>drug_type</span>: <span style='color: #555555;'>Drug Type: Identifies a drug as prescription (Rx) or Over-the-Counter (OTC). Numeric values; 1-digit field. Valid Values: 1 = Rx 2 = OTC</span>\n\n<span style='color: #555555;'>11</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>line_extension</span>: <span style='color: #555555;'>Line Extension Drug Indicator: Identifies whether a product is a line extension drug as defined in Section 1927(c)(2)(C) of the Social Security Act, including whether the drug is excluded from the statutory definition of a line extension on the basis of being an abuse-deterrent formulation (ADF). If a labeler is seeking an ADF exclusion, a value of R will appear in this field. Note: If a Line Extension Drug Indicator has not been reported for an NDC, this field will be blank. Valid Values: Y = Yes N = No (i.e., neither LE nor ADF) R = Request for ADF Exclusion E = Excluded (Due to ADF) Note: This value may only be assigned by CMS</span>\n\n<span style='color: #555555;'>12</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>fda_approval_date</span>: <span style='color: #555555;'>FDA Approval Date: NDA (including Authorized Generic), ANDA or BLA approval date. For covered outpatient drugs for which the FDA does not require approval, the FDA Approval Date will be 09/30/1990, or, if the drug was first marketed after 09/30/1990, the actual date the drug was first marketed.</span>\n\n<span style='color: #555555;'>13</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>market_date</span>: <span style='color: #555555;'>Market Date: For S, I, and N drugs marketed under an FDA-approved application (e.g. BLA, NDA, ANDA), the earliest date the drug was first marketed under the application number by any labeler. For drugs marketed without an FDA-approved application (e.g. OTC monograph, unapproved drug), the earliest date the drug was first marketed by any labeler. For all drugs (i.e., those marketed with or without an FDA-approved application), if a drug was purchased or otherwise acquired from another labeler, the Market Date should be equal to the Market Date of the original product. If a Market Date falls on a date that is earlier than 9/30/1990, CMS will change it to 9/30/1990 in the Medicaid Drug Programs (MDP) system since dates earlier than the start of the Drug Rebate Program have no bearing on the program.</span>\n\n<span style='color: #555555;'>14</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>unit_type</span>: <span style='color: #555555;'>Unit Type: One of the 10 unit types by which a drug may be dispensed. 3-character field; left-justified; blank-filled for Unit Type values with fewer than 3 characters. Valid Values: AHF = Injectable Anti-Hemophilic Factor CAP = Capsule EA = Each GM = Gram MCI = Millicurie ML = Milliliter UCI = Microcurie SUP = Suppository TAB = Tablet TDP = Transdermal patch</span>\n\n<span style='color: #555555;'>15</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>unit_per_package_size</span>: <span style='color: #555555;'>Units Per Package Size: The total number of units in the smallest dispensable amount for the 11-digit NDC. Numeric values; 11-digit field: 7 whole numbers, the decimal point (.') and 3 decimal places; right-justified; zero-padded for UPPS values with fewer than 11 digits.</span>\n\n<span style='color: #555555;'>16</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>therapeutic_equivalent_code</span>: <span style='color: #555555;'>Therapeutic Equivalence Code (TEC): FDA-assigned Therapeutic Equivalence Codes as found in the FDA's Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Alpha-numeric values; 2-digit field. Valid Values: AA = Products in Conventional Dosage Forms Not Presenting Bioequivalence Problems AB = Products Meeting Necessary Bioequivalence Requirements assigned an FDA TEC of AB, or AB1 through AB9 AN = Solutions and Powders for Aerosolization AO = Injectable Oil Solutions AP = Injectable Aqueous Solutions and, in Certain Instances, Intravenous Non-Aqueous AT = Topical Products BC = Extended-Release Dosage Forms (Capsules, Injectables, and Tablets) BD = Active Ingredients and Dosage Form With Documented Bioequivalence Problems BE = Delayed-Release Oral Dosage Forms BN = Products in Aerosol-Nebulizer Drug Delivery Systems BP = Active Ingredients and Dosage Forms with Potential Bioequivalence Problems BR = Suppositories or Enemas That Deliver Drugs for Systemic Absorption BS = Products Having Drug Standard Deficiencies BT = Topical Products with Bioequivalence Issues BX = Drug Products for Which the Data Are Insufficient To Determine Therapeutic Equivalence NR = Not Rated</span>\n\n<span style='color: #555555;'>17</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>5i_indicator</span>: <span style='color: #555555;'>The 5i Drug Indicator specifies whether or not the product is a 5i drug (i.e., inhaled, instilled, implanted, injected, or infused).  (Y or N)</span>\n\n<span style='color: #555555;'>18</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>purchased_product_date</span>: <span style='color: #555555;'>Purchased Product Date (PPD): The date the company currently holding legal title to the NDC first markets the drug under this NDC (this date can result, for example, from the purchase of an NDC from one company by another company, the re-designation of an NDC from one of a company's labeler codes to another of that same company's labeler codes, cross-licensing arrangements, etc.). Zero or blank-filled for drugs without Purchased Product Dates.</span>\n\n<span style='color: #555555;'>19</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>coverage_effective_date</span>: <span style='color: #555555;'>The Coverage Effective Date field reflects the date on which a product is first eligible for coverage under the MDRP.</span>\n\n<span style='color: #555555;'>20</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>drug_termination_date</span>: <span style='color: #555555;'>Termination Date: The date on which the drug was withdrawn from market or the drug's last lot expiration date.</span>\n\n<span style='color: #555555;'>21</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>drug_reactivation_date</span>: <span style='color: #555555;'>Reactivation Date: The date on which a terminated product is re-introduced to the market.</span>\n\n<span style='color: #555555;'>22</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>date_reported_to_cms</span>: <span style='color: #555555;'>Date Reported to CMS: The date on which the product was initially reported to CMS via MDP</span>\n</code></pre>\n:::\n\n\n### Drug Products\n\n\n::: {.cell layout-align=\"center\"}\n<pre class=\"r-output\"><code><span style='color: #555555;'> 1</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>year</span>: <span style='color: #555555;'>NA</span>\n\n<span style='color: #555555;'> 2</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>quarter</span>: <span style='color: #555555;'>NA</span>\n\n<span style='color: #555555;'> 3</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>labeler_name</span>: <span style='color: #555555;'>The corporate name of the entity identified by the labeler code.</span>\n\n<span style='color: #555555;'> 4</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>ndc</span>: <span style='color: #555555;'>The National Drug Code (NDC) is a numerical code maintained by the FDA that includes the labeler code, product code, and package code. The NDC is an 11-digit code.</span>\n\n<span style='color: #555555;'> 5</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>labeler_code</span>: <span style='color: #555555;'>The first segment of the National Drug Code that identifies the labeler.</span>\n\n<span style='color: #555555;'> 6</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>product_code</span>: <span style='color: #555555;'>The second segment of the National Drug Code that identifies the product.</span>\n\n<span style='color: #555555;'> 7</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>package_size_code</span>: <span style='color: #555555;'>The third segment of the National Drug Code that identifies the package size.</span>\n\n<span style='color: #555555;'> 8</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>drug_category</span>: <span style='color: #555555;'>This field indicates whether the drug is single source (S), innovator multiple source(I), or non- innovator multiple source (N). Valid Values: N = Non-innovator multiple source S = Single source I = Innovator multiple source</span>\n\n<span style='color: #555555;'> 9</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>drug_type_indicator</span>: <span style='color: #555555;'>This field identifies a drug as prescription (Rx) or Over-the-Counter (OTC). Valid values: 1 = Rx 2 = OTC</span>\n\n<span style='color: #555555;'>10</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>termination_date</span>: <span style='color: #555555;'>The date on which the drug was withdrawn from market or the drug's last lot expiration date.</span>\n\n<span style='color: #555555;'>11</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>unit_type</span>: <span style='color: #555555;'>One of the 8 unit types by which a drug can be dispensed. Valid Values: AHF = Injectable Anti-Hemophilic Factor CAP = Capsule SUP = Suppository GM = Gram ML = Milliliter TAB = Tablet TDP = Transdermal</span>\n\n<span style='color: #555555;'>12</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>units_per_pkg_size</span>: <span style='color: #555555;'>The total number of units in the smallest dispensable amount for the 11-digit NDC.</span>\n\n<span style='color: #555555;'>13</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>fda_approval_date</span>: <span style='color: #555555;'>The NDC or monograph approval date.</span>\n\n<span style='color: #555555;'>14</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>market_date</span>: <span style='color: #555555;'>For S, I, and N drugs marketed under an FDA-approved application (e.g. BLA, NDA, ANDA), the earliest date the drug was first marketed under the application number by any labeler. For drugs marketed without an FDA-approved application (e.g. OTC monograph, unapproved drug), the earliest date the drug was first marketed by any labeler. For all drugs (i.e., those marketed with or without an FDA-approved application), if a drug was purchased or otherwise acquired from another labeler, the Market Date should be equal to the Market Date of the original product. Thus, the Market Date of a drug is frequently not the date on which a labeler began marketing the drug, but may be a much earlier date. If a Market Date falls on a date that is earlier than 9/30/1990, CMS will change it to 9/30/1990 in both the Medicaid Drug Rebate (MDR) system and the Drug Data Reporting for Medicaid (DDR) system since dates earlier than the start of the Drug Rebate Program have no bearing on the program. Numeric values, 8-digit field, format: MM/DD/YYYY.</span>\n\n<span style='color: #555555;'>15</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>fda_therapeutic_equivalence_code</span>: <span style='color: #555555;'>The Therapeutic Equivalence Code (TEC) reported to CMS should correspond to the FDA Therapeutic Equivalence (TE) Code assigned to a product by the FDA. More information regarding FDA TE Codes can be found at the Orange Book at: http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm or Drugs@FDA at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Addlsearch_drug name. It is important to note that while the FDA generally assigns a two letter TE Code value (e.g., AB) to products, in some cases the value is two letters plus a number (e.g., AB1). Since DDR restricts values reported in the TEC field to two characters, some FDA TE Codes need to be converted to a two-character format. Specifically, if the FDA assigned TE Code is AB1, AB2, etc., the corresponding TEC value should be reported in DDR as A1, A2, etc. Alpha-numeric values, 2 character field. Valid Values: A1 A6 AB BC BR A2 A7 AN BD BS A3 A8 AO BE BT A4 A9 AP BN BX A5 AA AT BP NR (Not Rated)</span>\n\n<span style='color: #555555;'>16</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>fda_product_name</span>: <span style='color: #555555;'>The drug's name as approved by the FDA.</span>\n\n<span style='color: #555555;'>17</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>clotting_factor_indicator</span>: <span style='color: #555555;'>In accordance with section 1927(c)(1)(B)(iii) of the Social Security Act, an indicator which identifies a Single Source or Innovator Multiple Source drug as a clotting factor for which a separate furnishing payment is made under section 1842(o)(5) of the Act. Valid values: Y = Yes N = No</span>\n\n<span style='color: #555555;'>18</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>pediatric_indicator</span>: <span style='color: #555555;'>In accordance with section 1927(c)(1)(B)(iii) of the Social Security Act, an indicator which identifies a Single Source or Innovator Multiple Source drug approved by the FDA exclusively for pediatric indications for patients in the FDA-defined pediatric age group (i.e., birth to 16 years). Valid values: Y = Yes N = No</span>\n\n<span style='color: #555555;'>19</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>package_size_intro_date</span>: <span style='color: #555555;'>The date the package size is first available on the market. If the product was purchased from another company, the Package Size Introduction Date should equal the date the package size is first available on the market under the labeler code of the company currently holding legal title to the NDC.</span>\n\n<span style='color: #555555;'>20</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>purchased_product_date</span>: <span style='color: #555555;'>The date on which the company currently holding legal title to the NDC first markets the drug under this NDC (this date can result, for example, from the purchase of an NDC from one company by another company, the re-designation of an NDC from one of a company's labeler codes to another of that same company's labeler codes, cross-licensing arrangements, etc).</span>\n\n<span style='color: #555555;'>21</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>cod_status</span>: <span style='color: #555555;'>A category that identifies whether or not a product meets the statutory definition of a covered outpatient drug in accordance with sections 1927(k)(2) to 1927(k)(4) of the Social Security Act. Valid Values: ' ' (Spaces) = The Labeler has not reported this field to the Medicaid Drug Rebate Program. '01' = Abbreviated New Drug Application (ANDA) '02' = Biological License Application (BLA) '03' = New Drug Application (NDA) '04' = NDA Authorized Generic '05' = DESI 5* - LTE/IRS drug for all indications '06' = DESI 6* - LTE/IRS drug withdrawn from market '07' = Prescription Pre-Natal Vitamin or Fluoride '08' = Prescription Dietary Supplement/Vitamin/Mineral (Other than Prescription Pre-Natal Vitamin or Fluoride) '09' = OTC Monograph Tentative '10' = OTC Monograph Final '11' = Unapproved Drug - Drug Shortage '12' = Unapproved Drug - Per 1927(k)(2)(A)(ii) '13' = Unapproved Drug - Per 1927(k)(2)(A)(iii) *NDCs with a COD Status of DESI 5/6 are not eligible for coverage or rebates under the Medicaid Drug Rebate Program.</span>\n\n<span style='color: #555555;'>22</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>fda_application_number</span>: <span style='color: #555555;'>For drugs with a COD status of ANDA, BLA, NDA, or NDA Authorized Generic, this is the seven-digit application number that is assigned by the FDA for approval to market a generic drug or new drug in the United States  For drugs with a COD status of OTC Monograph Tentative or Final, this is the FDA's August 2018 Page 5 of 5 regulatory citation for the OTC  For drugs with a COD Status of OTC Monograph Final, the first four characters are a constant of PART; the last three characters are the numeric values for the appropriate regulatory citation for the product (e.g., '225')  For drugs with a COD Status of OTC Monograph Tentative, the first four characters area constant of 'PART'; the last three characters are the numeric values for the appropriate regulatory citation for the product, or 3 zeroes if a Monograph Number is not available  For drugs with a COD Status other than ANDA, BLA, NDA, NDA Authorized Generic, OTC Monograph Final, or OTC Monograph Tentative, the FDA Application No./OTC Monograph No. field will be zero-filled For drugs where a COD Status has never been reported to CMS, the FDA Application Number/OTC Monograph Number field will be padded with spaces.</span>\n\n<span style='color: #555555;'>23</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>reactivation_date</span>: <span style='color: #555555;'>The date on which a terminated product is re-introduced to the market.</span>\n\n<span style='color: #555555;'>24</span> <span style='color: #BB0000; font-weight: bold; text-decoration: underline;'>line_extension_drug_indicator</span>: <span style='color: #555555;'>Identifies whether or not a product is a line extension drug as defined inSection 1927(c)(2)(C) of the Social SecurityAct, including whether the drug is excluded from the statutory definition of a line extension on the basis of being an abuse-deterrent formulation (ADF). Valid Values: Y = Yes N = No (i.e., neither LE nor ADF) R = Request for ADF Exclusion E = Excluded (Due to ADF) (NOTE: This value may only be assigned by CMS)</span>\n</code></pre>\n:::\n\n\n:::\n\n## Endpoint\n\n\n::: {.cell layout-align=\"center\"}\n<pre class=\"r-output\"><code><span style='color: #555555;'># A tibble: 932 × 17</span>\n   ndc1  ndc2  ndc3  ndc11       fda_nameproduct_name                 cod_status\n   <span style='color: #555555; font-style: italic;'><chr></span> <span style='color: #555555; font-style: italic;'><chr></span> <span style='color: #555555; font-style: italic;'><chr></span> <span style='color: #555555; font-style: italic;'><chr></span>       <span style='color: #555555; font-style: italic;'><chr></span>                                <span style='color: #555555; font-style: italic;'><fct></span>     \n<span style='color: #555555;'> 1</span> 00006 5331  01    00006533101 WELIREG 40MG TABLET                  03        \n<span style='color: #555555;'> 2</span> 00093 3420  01    00093342001 CYCLOBENZAPRINE HCL 5MG TABLETS 100  01        \n<span style='color: #555555;'> 3</span> 00093 3421  01    00093342101 CYCLOBENZAPRINE HCL 7.5MG TABLETS 1… 01        \n<span style='color: #555555;'> 4</span> 00093 3422  01    00093342201 CYCLOBENZAPRINE HCL 10MG TABLETS 100 01        \n<span style='color: #555555;'> 5</span> 00093 3422  05    00093342205 CYCLOBENZAPRINE HCL 10MG TABLETS 500 01        \n<span style='color: #555555;'> 6</span> 00113 7032  40    00113703240 MINOXIDIL 5% 180 DAY LIQ 12OZ        01        \n<span style='color: #555555;'> 7</span> 00115 1010  03    00115101003 Baclofen 10MG                        01        \n<span style='color: #555555;'> 8</span> 00143 9361  01    00143936101 MICAFUNGIN LYO for INJ 50mg x 1      01        \n<span style='color: #555555;'> 9</span> 00143 9362  01    00143936201 MICAFUNGIN LYO for INJ 100mg x 1     01        \n<span style='color: #555555;'>10</span> 00378 0399  18    00378039918 Dimethyl Fumarate DR 240mg C  60s G… 01        \n<span style='color: #555555;'># ℹ 922 more rows</span>\n<span style='color: #555555;'># ℹ 11 more variables: fda_application_numberotc_monograph_number <chr>,</span>\n<span style='color: #555555;'>#   drug_category <fct>, drug_type <fct>, unit_type <fct>, upps <dbl>,</span>\n<span style='color: #555555;'>#   line_extension <chr>, tec_code <fct>, fda_approval_date <date>,</span>\n<span style='color: #555555;'>#   market_date <date>, termination_date <date>, date_transferred <date></span>\n</code></pre>\n:::\n\n\n## Overview\n\n::: panel-tabset\n\n### Summary\n\n\n::: {.cell layout-align=\"center\"}\n<pre class=\"r-output\"><code>obs: 932 \ncols: 17 \n\n----- Numeric -----\n   col n_missng p_complt n_unique mean   p0 p25 p50 p75 p100 iqr  sd  hist\n1 upps        0        1       71 86.6 0.14   1  25 100 1000  99 185 ▇▁▁▁▁\n\n----- Dates -----\n             col n_missng p_complt n_unique        min        max\n1 fda_approvl_dt        0        1      367 1990-09-30 2021-09-15\n2    market_date        0        1      367 1990-09-30 2021-09-15\n3 termination_dt      932        0        0       <NA>       <NA>\n4 date_transfrrd      932        0        0       <NA>       <NA>\n\n----- Categorical -----\n              col n_missng p_complt n_unique n_levels\n1            ndc1        0        1      170       NA\n2            ndc2        0        1      576       NA\n3            ndc3        0        1       76       NA\n4           ndc11        0        1      932       NA\n5  fda_nmprdct_nm        0        1      779       NA\n6      cod_status        0        1        9        9\n7  fd_pplctn_nm__        0        1      385       NA\n8   drug_category        0        1        3        3\n9       drug_type        0        1        2        2\n10      unit_type        0        1        8        8\n11 line_extension      932        0        0       NA\n12       tec_code        0        1       10       10\n                                                     min\n1                                                  00006\n2                                                   0001\n3                                                     00\n4                                            00006533101\n5  2.5% Dextrose and 0.45% Sodium Chl Liquid 25 g 1000mL\n6                                                     01\n7                                                       \n8                                                      I\n9                                                      1\n10                                                   AHF\n11                                                  <NA>\n12                                                    A1\n                                    max\n1                                 78206\n2                                  9398\n3                                    99\n4                           78206018201\n5  micafungin sodium 20mg/ml 1 5ml vial\n6                                    12\n7                               PART356\n8                                     S\n9                                     2\n10                                  TDP\n11                                 <NA>\n12                                   NR\n</code></pre>\n:::\n\n\n### Distribution\n\n\n::: {.cell layout-align=\"center\"}\n<pre class=\"r-output\"><code>Variable |  Mean |     SD | IQR |           Range | Skewness | Kurtosis |   n | n_Missing\n-----------------------------------------------------------------------------------------\nupps     | 86.62 | 185.27 |  99 | [0.14, 1000.00] |     3.60 |    13.55 | 932 |         0\n</code></pre>\n:::\n\n\n### Plots\n\n\n::: {.cell layout-ncol=\"2\" layout-align=\"center\"}\n::: {.cell-output-display}\n![](caid_rebate_files/figure-html/distribution_plot-1.png){fig-align='center' width=70%}\n:::\n:::\n\n\n::: \n",
    "supporting": [
      "caid_rebate_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}